Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03155672 · ClinicalTrials.gov registry record

A Phase I, Single-center, Mixed Methods Study ON THE Health Outcomes OF Visual Self Expression

A clinical trial of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
80
Enrollment target
1
Study location

NCT03155672 is a study of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03155672, a study of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

To gain understanding about the impact of visual art making on biomarkers, such as cortisol, alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in levels of stress and immune function in patients and caregivers adults (including family caregivers and medical professionals)

Interventions

  • BEHAVIORAL Art therapy

Study Locations (1)

Pennsylvania

  • Abramson Cancer Center of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2017-05-15
Est. Completion 2019-12-31

What the Registry Record Tells You About NCT03155672

The ClinicalTrials.gov registry entry for NCT03155672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania appearing as the primary indexed condition, and to 1 intervention - of which Art therapy is the first listed.

NCT03155672 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03155672 about?

NCT03155672 is a clinical study titled "A Phase I, Single-center, Mixed Methods Study ON THE Health Outcomes OF Visual Self Expression". To gain understanding about the impact of visual art making on biomarkers, such as cortisol, alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in levels of stress and immune function in patients and caregivers adults (including family caregivers and medical profes...

What is the current status of trial NCT03155672?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-05-15. Estimated completion is 2019-12-31.

What conditions does trial NCT03155672 study?

This clinical trial studies the following conditions: A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania.

What interventions are being tested in trial NCT03155672?

The interventions under investigation include: Art therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03155672?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03155672 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.